Dopamine agonists modify the course of Parkinson disease.
Stern
Matthew B
MB
Penn Neurologic Institute, 330 S. 9th Street, Philadelphia, PA 19107, USA. mbstern@mail.med.upenn.edu
D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism
D018491:Dopamine Agonists; D018696:Neuroprotective Agents